Sivan Weiss

Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels

Leif Bjermer, Catherine Lemière, Jorge Máspero et al. · CHEST Journal · 2016 · 426 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects

Orit Cohen‐Barak, Sivan Weiss, Michèle Rasamoelisolo et al. · Cephalalgia · 2018 · 54 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users

Megan J. Shram, Orit Cohen‐Barak, Bijan Chakraborty et al. · Journal of Clinical Psychopharmacology · 2015 · 51 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Glatiramer acetate treatment in PPMS: Why males appear to respond favorably

Jerry S. Wolinsky, Tzippy Shochat, Sivan Weiss et al. · Journal of the Neurological Sciences · 2009 · 40 citations

Medicine, Pharmacology, Pharmacotherapy +3

Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy

Guy Brusselle, Janice Canvin, Sivan Weiss et al. · ERJ Open Research · 2017 · 18 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +14